Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Jubilant Pharmova Ltd Q4FY25; 10% rise in Revenue
Categories
Novel Drugs
Jubilant Pharmova Ltd Q4FY24; 5% rise in Revenue
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Jubilant Pharmova Ltd Q3FY24; 8% rise in Revenue
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Biocon Q2FY23 results out: Revenue up by 26%
Biocon Ltd reported a 49 percent slump in consolidated net profit at INR 82 crore for the quarter ended September 30, 2022.
Jubilant Pharmova reports dip in its net profit by 97% for Q2FY23
Jubilant Pharmova reported total income of INR 1,599.5 crores during the period ended September 30, 2022 as compared to INR 1,657.7 crores
Jubilant Pharmova reports dip in its net profit by 71% for Q1FY23
Jubilant Pharmova reported total income of INR 1,452 crores during the period ended June 30, 2022 as compared to INR 1,635 crores
Infographic: Biocon opens this year with a stellar performance reporting 71% growth in profits
Biocon on Wednesday reported 71% year-on-year (YoY) jump in net profit to Rs 144 crore during Q1FY23, driven by sales of biosimilar